FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947673744> ?p ?o ?g. }

• W2947673744 abstract "Background Although observational studies suggest people with systemic lupus erythematosus (SLE) have a heightened risk of venous thromboembolic events (VTE), meta-analyses that integrate evidence across studies to estimate the pooled risk have not been performed. Objectives To conduct a systematic review and meta-analysis to estimate the risk of VTE including pulmonary embolism (PE) and deep vein thrombosis (DVT) in patients with SLE. Methods We conducted a systematic review using MEDLINE and EMBASE from inception to March 2018 to identify observational studies (cohort and cross-sectional) that evaluated the risk of several major cardiovascular outcomes in patients with SLE compared to a general population or healthy controls (protocol published in PROSPERO 2018 CRD42018098690). Here we report the results for venous thromboembolic outcomes. Studies were included that provided effect estimates (relative risks or hazard ratios) for the calculation of pooled effect estimates. Random effects models were used to calculate pooled risk ratios (RR) and 95% confidence intervals (CI) separately for VTE, PE and DVT. Visualization of funnel plots and the Egger’s test were used for evaluation of publication bias. The robustness of the results was tested using the leave one out function. Sensitivity analysis assessed the impact of removing high risk of bias studies (i.e. cross-sectional). Results A total of 9 studies were identified for inclusion into the meta-analysis; 7 for VTE (including two cross-sectional studies), 3 for DVT and 4 for PE. Meta-analysis of the VTE studies showed a significantly increased RR of 3.67 (95% CI: 2.10 to 6.42) for patients with SLE compared to a general population. Removing the two cross-sectional studies did not impact the results (RR 4.06 [95% CI: 3.12 to 5.28]). The pooled RRs for PE and DVT were 4.47 (95% CI: 1.79 to 11.15) and 5.51 (95% CI: 2.27 to 13.39), respectively. The statistical heterogeneity was high with an I2 ranging between 92% and 99%. Visual examination of the funnel plots showed evidence of publication bias, however this was not supported by the Egger’s test. The leave one out function confirmed the robustness of the results. Conclusion Overall, the risk of VTE was found to be significantly higher, over three- to six-fold higher, among patients with SLE compared with the general population. Future research should focus on assessing the impact of traditional and SLE-specific modifiable risk factors on VTE to further identify SLE patients most at risk to support targeting prevention and treatment strategies. References [1] Ahlehoff O, et al. Lupus. 2017;26:1435–1439. Avina-Zubieta JA, et al. Semin Arthritis Rheum. 2015;45:195–201. Chung WS, et al. J Thromb Haemost. 2014;12:452–458. Dregan A, et al. Heart. 2017;103:1867–1873. Johannesdottir SA, et al. J Thromb Haemost. 2012;10:815–821. Mok CC, et al. Clin Rheumatol. 2010;29:599–604. Ramagopalan SV, et al. BMC Med. 2011;9:1. Yusuf HR, et al. J Thromb Thrombolysis. 2014;38:306–313. Zoller B, et al. Lancet. 2012;379:244–249. Disclosure of Interests Nick Pooley Consultant for: I am employed by Maverex who were paid to conduct this systematic literature review on behalf of AstraZeneca., Jinoos Yazdany Grant/research support from: Pfizer, Consultant for: AstraZeneca, Julia Langham Consultant for: I am employed by Maverex who were paid to conduct this systematic literature review on behalf of AstraZeneca., Lindsay Nicholson Consultant for: I am employed by Maverex who were paid to conduct this systematic literature review on behalf of AstraZeneca., Sue Langham Consultant for: I am employed by Maverex who were paid to conduct this systematic literature review on behalf of AstraZeneca., Nina Embleton Consultant for: I am employed by Maverex who were paid to conduct this systematic literature review on behalf of AstraZeneca., Xia Wang Shareholder of: AstraZeneca, Employee of: AstraZeneca, Barnabas Desta Employee of: AstraZeneca, Volkan Barut Employee of: AstraZeneca, Edward R. Hammond Employee of: AstraZeneca" @default.
• W2947673744 created "2019-06-07" @default.
• W2947673744 creator A5011413788 @default.
• W2947673744 creator A5018094277 @default.
• W2947673744 creator A5022215155 @default.
• W2947673744 creator A5027451778 @default.
• W2947673744 creator A5039789041 @default.
• W2947673744 creator A5049798132 @default.
• W2947673744 creator A5058336621 @default.
• W2947673744 creator A5073798135 @default.
• W2947673744 creator A5079227036 @default.
• W2947673744 creator A5083785350 @default.
• W2947673744 date "2019-06-01" @default.
• W2947673744 modified "2023-09-27" @default.
• W2947673744 title "FRI0249 THE RISK OF VENOUS THROMBOEMBOLIC EVENTS IN ADULT PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: SYSTEMATIC REVIEW AND META-ANALYSIS" @default.
• W2947673744 doi "https://doi.org/10.1136/annrheumdis-2019-eular.3381" @default.
• W2947673744 hasPublicationYear "2019" @default.
• W2947673744 type Work @default.
• W2947673744 sameAs 2947673744 @default.
• W2947673744 citedByCount "1" @default.
• W2947673744 countsByYear W29476737442020 @default.
• W2947673744 crossrefType "proceedings-article" @default.
• W2947673744 hasAuthorship W2947673744A5011413788 @default.
• W2947673744 hasAuthorship W2947673744A5018094277 @default.
• W2947673744 hasAuthorship W2947673744A5022215155 @default.
• W2947673744 hasAuthorship W2947673744A5027451778 @default.
• W2947673744 hasAuthorship W2947673744A5039789041 @default.
• W2947673744 hasAuthorship W2947673744A5049798132 @default.
• W2947673744 hasAuthorship W2947673744A5058336621 @default.
• W2947673744 hasAuthorship W2947673744A5073798135 @default.
• W2947673744 hasAuthorship W2947673744A5079227036 @default.
• W2947673744 hasAuthorship W2947673744A5083785350 @default.
• W2947673744 hasBestOaLocation W29476737441 @default.
• W2947673744 hasConcept C126322002 @default.
• W2947673744 hasConcept C17744445 @default.
• W2947673744 hasConcept C189708586 @default.
• W2947673744 hasConcept C199539241 @default.
• W2947673744 hasConcept C201903717 @default.
• W2947673744 hasConcept C207103383 @default.
• W2947673744 hasConcept C23131810 @default.
• W2947673744 hasConcept C2776265017 @default.
• W2947673744 hasConcept C2778959117 @default.
• W2947673744 hasConcept C2779473830 @default.
• W2947673744 hasConcept C2780011451 @default.
• W2947673744 hasConcept C2780439572 @default.
• W2947673744 hasConcept C2780868729 @default.
• W2947673744 hasConcept C2908647359 @default.
• W2947673744 hasConcept C44249647 @default.
• W2947673744 hasConcept C71924100 @default.
• W2947673744 hasConcept C82605166 @default.
• W2947673744 hasConcept C82789193 @default.
• W2947673744 hasConcept C95190672 @default.
• W2947673744 hasConcept C99454951 @default.
• W2947673744 hasConceptScore W2947673744C126322002 @default.
• W2947673744 hasConceptScore W2947673744C17744445 @default.
• W2947673744 hasConceptScore W2947673744C189708586 @default.
• W2947673744 hasConceptScore W2947673744C199539241 @default.
• W2947673744 hasConceptScore W2947673744C201903717 @default.
• W2947673744 hasConceptScore W2947673744C207103383 @default.
• W2947673744 hasConceptScore W2947673744C23131810 @default.
• W2947673744 hasConceptScore W2947673744C2776265017 @default.
• W2947673744 hasConceptScore W2947673744C2778959117 @default.
• W2947673744 hasConceptScore W2947673744C2779473830 @default.
• W2947673744 hasConceptScore W2947673744C2780011451 @default.
• W2947673744 hasConceptScore W2947673744C2780439572 @default.
• W2947673744 hasConceptScore W2947673744C2780868729 @default.
• W2947673744 hasConceptScore W2947673744C2908647359 @default.
• W2947673744 hasConceptScore W2947673744C44249647 @default.
• W2947673744 hasConceptScore W2947673744C71924100 @default.
• W2947673744 hasConceptScore W2947673744C82605166 @default.
• W2947673744 hasConceptScore W2947673744C82789193 @default.
• W2947673744 hasConceptScore W2947673744C95190672 @default.
• W2947673744 hasConceptScore W2947673744C99454951 @default.
• W2947673744 hasLocation W29476737441 @default.
• W2947673744 hasOpenAccess W2947673744 @default.
• W2947673744 hasPrimaryLocation W29476737441 @default.
• W2947673744 hasRelatedWork W2027865536 @default.
• W2947673744 hasRelatedWork W2031102521 @default.
• W2947673744 hasRelatedWork W2272283336 @default.
• W2947673744 hasRelatedWork W2510766428 @default.
• W2947673744 hasRelatedWork W2568080585 @default.
• W2947673744 hasRelatedWork W2585911098 @default.
• W2947673744 hasRelatedWork W2606606817 @default.
• W2947673744 hasRelatedWork W2726097771 @default.
• W2947673744 hasRelatedWork W2898248848 @default.
• W2947673744 hasRelatedWork W2950668291 @default.
• W2947673744 hasRelatedWork W2993231111 @default.
• W2947673744 hasRelatedWork W3005282054 @default.
• W2947673744 hasRelatedWork W3047622600 @default.
• W2947673744 hasRelatedWork W3081694682 @default.
• W2947673744 hasRelatedWork W3113988521 @default.
• W2947673744 hasRelatedWork W3136718711 @default.
• W2947673744 hasRelatedWork W3143871679 @default.
• W2947673744 hasRelatedWork W3160881920 @default.
• W2947673744 hasRelatedWork W2332360940 @default.
• W2947673744 hasRelatedWork W2515922650 @default.
• W2947673744 isParatext "false" @default.
• W2947673744 isRetracted "false" @default.
• W2947673744 magId "2947673744" @default.
• W2947673744 workType "article" @default.